CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1997; 47:70
doi: 10.3322/canjclin.47.2.70
© 1997 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jessup, J. M.
Right arrow Articles by Winchester, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jessup, J. M.
Right arrow Articles by Winchester, D. P.

CA: A Cancer Journal for Clinicians, Vol 47, Issue 2 70-92, Copyright © 1997 by American Cancer Society


ARTICLES

Diagnosing colorectal carcinoma: clinical and molecular approaches

J. M. Jessup, H. R. Menck, A. Fremgen and D. P. Winchester
Department of Surgery at New England Deaconess Hospital, Boston, Massachusetts, USA.

In summary, the ability to decrease the mortality of colorectal carcinoma is increasingly within the grasp of clinicians. With accurate family and personal history, it is possible to estimate the risk of colorectal cancer and initiate FOBT and colonoscopy where appropriate. In the future, germline and even somatic genetic testing will further increase our ability to diagnose cancers before they become widely invasive. As molecular biology unravels the cause of what currently appears to be the majority of sporadic cancers, it may be possible to characterize more colorectal cancers that are caused by novel, as yet not recognized mutator genes. Unfortunately, a set of patients is likely to exist who remain to be diagnosed by symptoms caused by advanced cancer. The goal for the clinician is to decrease this subset to as small a group as possible.


This article has been cited by other articles:


Home page
Arch SurgHome page
G. Ercolani, G. L. Grazi, M. Ravaioli, M. Cescon, A. Gardini, G. Varotti, M. Del Gaudio, B. Nardo, and A. Cavallari
Liver Resection for Multiple Colorectal Metastases: Influence of Parenchymal Involvement and Total Tumor Volume, vs Number or Location, on Long-term Survival
Arch Surg, October 1, 2002; 137(10): 1187 - 1192.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by American Cancer Society.